[pThr3]-CDK5 Substrate (TFA)

CAS No. ——

[pThr3]-CDK5 Substrate (TFA)( —— )

Catalog No. M30359 CAS No. ——

[pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    [pThr3]-CDK5 Substrate (TFA)
  • Note
    Research use only, not for human use.
  • Brief Description
    [pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 μM.
  • Description
    [pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    1332.45
  • Molecular Formula
    C55H101F3N15O17P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Pro}{Lys}{pTHR}{Pro}{Lys}{Lys}{Ala}{Lys}{Lys}{Leu}

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Beaudette KN, et al. Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain. J Biol Chem. 1993 Oct 5;268(28):20825-30.
molnova catalog
related products
  • Sulforhodamine 101

    Sulforhodamine 101 is a red fluorescent dye.

  • Methyl dec-9-enoate

    Methyl dec-9-enoate (9-Decenoic acid methyl ester) is an olefin ester oil displacing agent, and is a raw material for coatings, inks and plastic additives.

  • (S,R,S)-AHPC-C4-NH2 ...

    (S,R,S)-AHPC-C4-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and a linker.